Traditional biomarkers such as BNP and NT-proBNP remain essential indicators of myocardial stress and volume overload, whereas multi-marker strategies integrating ST2, Galectin-3, and Copeptin provide deeper insight into HF pathophysiology and potential therapeutic targets (215–219). This evidence concerns the gene NPPB and hydrops fetalis.